Histopathological Patterns of Prostatic Lesions with Serum PSA Correlation

Read full text Summarise with VIRAT
Authors: Ratnesh Kumar, Arundhati Arundhati, Manish Kumar
Cited by: 0
References: 8

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Malignant neoplasms and benign inflammatory diseases are both examples of prostate lesions. PSA, or serum prostate-specific antigen, is frequently used as a diagnostic and screening tool. The accuracy of diagnosis is improved when serum PSA levels and histopathological findings are correlated. Aim: To compare serum PSA levels with the histological spectrum of prostatic lesions. Methods: 110 prostate specimens that were received by the Department of Pathology were included in a one-year retrospective research. Records were searched for clinical information, serum PSA levels, and histopathological results. Among the specimens were samples from prostatectomy, needle biopsies, and transurethral resection of the prostate (TURP). Analysis was done on the statistical relationship between PSA levels and histological diagnosis. Results: The largest age group among 110 cases was 60–69 years old (43.6%). The most prevalent lesion (58.1%) was benign prostatic hyperplasia (BPH). A significant correlation (p10 ng/mL) and cancer. The highest mean PSA values were found in cases of carcinoma (32.3 ng/mL), prostatitis (14.3 ng/mL), and BPH (6.6 ng/mL). Conclusion: The most prevalent prostatic lesion is still BPH. Nonetheless, there is a clear correlation between malignant tumors and noticeably high PSA readings. The most reliable method for making a conclusive diagnosis is still histopathological analysis.

Fields of Study & Subjects

Prostate Cancer Diagnosis and Treatment Urinary Bladder and Prostate Research Urologic and reproductive health conditions

Publication details

Journal / source
International Journal of Current Pharmaceutical Review and Research
Volume
18
Issue
01
Publication date
30 January 2026
Language
EN